Proteins of the SIR2 (Silent Information Regulator 2) family are characterized by a conserved catalytic domain that exerts unique NAD + -dependent deacetylase activity on histones and various other cellular substrates. Previous reports from us have identified a Leishmania infantum gene encoding a cytosolic protein termed LiSIR2RP1 (Leishmania infantum SIR2-related protein 1) that belongs to the SIR2 family. Targeted disruption of one LiSIR2RP1 gene allele led to decreased amastigote virulence, in vitro as well as in vivo. In the present study, attempts were made for the first time to explore and characterize the enzymatic functions of LiSIR2RP1. The LiSIR2RP1 exhibited robust NAD + -dependent deacetylase and ADP-ribosyltransferase activities. Moreover, LiSIR2RP1 is capable of deacetylating tubulin, either in dimers or, when present, in taxol-stabilized microtubules or in promastigote and amastigote extracts. Furthermore, the immunostaining of parasites revealed a partial co-localization of α-tubulin and LiSIR2RP1 with punctate labelling, seen on the periphery of both promastigote and amastigote stages. Isolated parasite cytoskeleton reacted with antibodies showed that part of LiSIR2RP1 is associated to the cytoskeleton network of both promastigote and amastigote forms. Moreover, the Western blot analysis of the soluble and insoluble fractions of the detergent of promastigote and amastigote forms revealed the presence of α-tubulin in the insoluble fraction, and the LiSIR2RP1 distributed in both soluble and insoluble fractions of promastigotes as well as amastigotes. Collectively, the results of the present study demonstrate that LiSIR2RP1 is an NAD + -dependent deacetylase that also exerts an ADP-ribosyltransferase activity. The fact that tubulin could be among the targets of LiSIR2RP1 may have significant implications during the remodelling of the morphology of the parasite and its interaction with the host cell.
INTRODUCTION
The yeast SIR2 (Silent Information Regulator 2) protein is the founding member of a large conserved family of proteins that are present in many organisms ranging from bacteria to humans [1] . This protein is an NAD + -dependent HDAC (histone deacetylase) that modulates chromatin structure and silences the transcription at the level of the silent mating type loci, telomeres and ribosomal DNA [2] [3] [4] . In addition to epigenetic silencing, the yeast SIR2 also has a role in DNA repair, recombination and DNA replication [5] . The first evidence that the SIR2 proteins could be involved in functions other than transcriptional silencing came from the presence of the LmSIR2 (Leishmania major SIR2)-related protein in cytoplasmic granules [6] . Seven SIR2 genes were identified in humans, and the proteins, classified as sirtuins (SIRT1-7), present several subcellular localizations [7, 8] . However, not all of the sirtuin family members seem to be active deacetylases [9, 10] . SIRT1 is localized in the nucleus and deacetylates histones H3 and H4, p53, TAF168 and PCAF [p300/CREB (cAMP-response-element-binding protein)-binding protein-associated factor]/MyoD [4, [11] [12] [13] [14] . Despite the cytosolic localization of SIRT2 and its ability to deacetylate α-tubulin, this protein shuttles the nucleus during G 2 /M-phase transition and thus plays a role in the regulation of microtubule dynamics and cell cycle progression [15] [16] [17] . SIRT3 was found in the mitochondria controlling the activity of the acetyl-CoA synthetase 2 [18] . Histone and non-histone substrates are deacetylated by sirtuins in the presence of NAD + and lead to the production of the deacetylated protein, nicotinamide and OAADPr (O-acetyl-ADPribose) [19, 20] . Several questions have been raised on understanding the NAD + -dependency of the sirtuin, since there is no energetic reason that favours the coupling. Among the possibilities is the connection between the proteins deacetylation and the metabolic status of the cell or the formation of a second messenger, OAADPr [20] .
Some members of the SIR2 family, such as the yeast SIR2, the human SIRT2, the mouse SIRT6, the Trypanosoma brucei SIR2RP1 and the Plasmodium falciparum SIR2, exhibit ADPribosyltransferase activity [7, [21] [22] [23] [24] . This kind of enzymatic activity was for the first time attributed to this family of proteins Abbreviations used: APC, antigen-presenting cell; DAPI, 4 ,6-diamidino-2-phenylindole; FBS, foetal calf serum; HDAC, histone deacetylase; LicTXNPx, Leishmania infantum cytosolic peroxiredoxin; OAADPr, O-acetyl-ADP-ribose; SIR2, Silent Information Regulator 2; LiSIR2RP1, Leishmania infantum SIR2-related protein 1; LmSIR2, Leishmania major SIR2; SIRT, sirtuin; rLiSIR2RP1, recombinant LiSIR2RP1; rSIRT1, recombinant SIRT1; TCA, trichloroacetic acid; TSA, trichostatin A; wt, wild-type. 1 Both of these authors have supervised the implementation of the present study. 2 To whom correspondence should be addressed (email cordeiro@ibmc.up.pt).
due to the ability of the Salmonella typhimurium SIR2 homologue, Cob B, to compensate for the loss of Cob T in cobalamine biosynthesis [25] . Additionally, sirtuins, and particularly the one associated with caloric restriction regimens in several organisms such as Caenorhabditis elegans, yeast and fly might also be involved in longevity [26] [27] [28] .
The agent of leishmaniasis, the protozoan parasite Leishmania, is responsible for serious diseases characterized by diverse clinical manifestations varying from localized ulcerative skin lesions and destructive mucosal inflammation to the disseminated visceral infection also known as kala-azar. The visceral leishmaniasis caused by L. infantum is a serious problem throughout the Mediterranean basin, where dogs are the most important reservoirs of the parasite. A vertebrate host becomes infected by Leishmania after the bite of a sandfly (Phlebotomus and Lutzomya spp) during a blood meal, through the inoculation of infective flagellated promastigotes that invade, or are phagocytosed by, local or recruited host cells. In the phagolysosomes, the promastigotes will differentiate into non-flagellated amastigotes that multiply and are able to infect other adjacent or distant macrophages. The classical treatment is currently unsatisfactory owing to side effects, the appearance of resistance and the need for increased efficacy in immunosuppressed patients, especially due to HIV co-infection. Over last few years, our group has been interested in the Leishmania SIR2 proteins due to the role of LiSIR2RP1 (L. infantum SIR2-related protein 1) in the survival and virulence of the parasite [29, 30] .
Although few reports have disclosed SIR2 protein function in protozoan parasites such as P. falciparum, whose PfSIR2, localized in the nucleus, is involved in var gene silencing through heterochromatin formation [31] , and T. brucei, which has a chromosome-associated NAD + -dependent deacetylase and ADPribosyltransferase that confers resistance to DNA damage [22] , little is known about the biological properties of Leishmania cytosolic LiSIR2RP1. In the present study, we provide molecular and biochemical evidence supporting the notion that LiSIR2RP1 is an NAD + -dependent deacetylase enzyme that may also express ADP-ribosyltransferase activity. In addition, we show that the protein deacetylates α-tubulin and is partially associated with the microtubule network. Further studies on LiSIR2RP1 may provide new insights into the relationships among cytoskeleton dynamics, stage transition and parasite-host cell interaction.
EXPERIMENTAL

Parasites
The L. infantum (clone MHOM/MA/67/ITMAP-263) wt (wildtype) promastigotes were grown at 27
• C in RPMI 1640 medium (Cambrex) supplemented with 10 % (v/v) heat-inactivated FBS (foetal bovine serum; Cambrex), 2 mM L-glutamine (Cambrex), 20 mM Hepes (Cambrex), 100 units/ml penicillin (Cambrex) and 100 μg/ml streptomycin (Cambrex). L. infantum axenic amastigote forms were grown at 37
• C with 5 % CO 2 in a cellfree medium called MAA/20 (medium for axenic amastigotes). MAA/20 consisted of modified medium 199 (Gibco) with Hanks balanced salt solution supplemented with 0.5 % trypto-casein (Oxoid), 15 mM D-glucose (Sigma), 5 mM glutamine (Cambrex), 4 mM NaHCO 3 (Sigma), 0.023 mM bovine haemin (Fluka) and 25 mM Hepes to a pH of 5.8 and supplemented with 20 % heat-inactivated FBS. The heterozygote LiSIR2 +/− derived from the wt clone was generated as previously described [30] and maintained in their respective selective medium. The levels of LiSIR2 synthesis in LiSIR2
+/− and wt parasites were evaluated by Western blotting, using an anti-LiSIR2 monoclonal antibody as described previously [30] .
Heterologous expression and purification of LiSIR2RP1
The LiSIR2RP1-encoding sequence (GenBank accession number AF487351) from L. infantum genomic DNA was amplified by PCR using two primers, a forward primer (5 -CAATTTGCATAT-GACAGCGTCTCCGAGAGCGCC A-3 ) and a reverse primer (5 -CCCAAGCGAATTCTCACGTCTCATTCGGCGC-3 ). The amplified product of approx. 1200 bp was cloned into the NdeI and EcoRI restriction sites of the prokaryotic expression vector pET28a (Novagen) and the fusion protein LiSIR2RP1 with an Nterminal tail of six histidine residues was produced in Escherichia coli BL21(DE3). The transformants were grown in a Luria Broth medium containing 30 μg/ml kanamycin, and recombinant protein expression was induced in mid-exponential phase with 1 mM IPTG (isopropyl β-D-thiogalactoside) for 3 h at 37
• C. The bacterial pellet was resuspended in a buffer containing 500 mM NaCl and 20 mM Tris/HCl (pH 7.6) and disrupted by sonication. The clarified supernatant was applied to a Ni-NTA (Ni 2+ -nitrilotriacetate)-agarose column (Qiagen) and the recombinant LiSIR2RP1 protein was eluted with an imidazole gradient from 25 to 1000 mM. The eluted fractions were controlled for the presence of LiSIR2RP1 using SDS/PAGE. The fractions containing the recombinant protein were pooled, applied to PD-10 columns (Amersham Pharmacia Biotech) and eluted with PBS (pH 7.4).
Deacetylase assay
The NAD + -dependent deacetylase activity was evaluated by using a commercially available SIRT1/Sir2 deacetylase fluorometric assay kit (CycLex). The enzymatic reaction containing 0.25 μg of rLiSIR2RP1 (recombinant LiSIR2RP1) was carried out in accordance with the manufacturer's protocol and was monitored every 30 s for 1 h. The results are expressed as the rate of reaction for the first 20 min, when there was a linear correlation between the fluorescence and this period of time.
Tubulin deacetylation assay
The tubulin deacetylation reactions were performed using either purified tubulin (Pure tubulin; Cytoskeleton) or L. infantum promastigote and axenic amastigote extracts, prepared in PEM buffer [80 mM Pipes (pH 6.8), 1 mM MgCl 2 and 1 mM EGTA] by sonication. In both cases, the tubulin was either left as heterodimers, or polymerized in PEM buffer in the presence of 20 μM taxol (Cytoskeleton) and 1 mM GTP (Cytoskeleton) for 45 min at 37
• C. The reactions were carried out in deacetylase buffer [10 mM Tris/HCl (pH 8.0) and 10 mM NaCl], in the presence or absence of 1 mM NAD + with constant agitation at room temperature (22 • C) for 3 h. The reactions were stopped by adding 5 × Laemmli sample buffer and the proteins separated by SDS/PAGE (10 % gels) and Western blotted.
ADP-ribosylation assays
The ADP-ribosylation assays were performed as described by Garcia-Salcedo et al. [22] . Briefly, the assays were carried out with 1 μg of either of the following proteins: rLiSIR2RP1, rSIRT1 (recombinant human SIRT1; in the CycLex kit), or with the recombinant LicTXNPx (L. infantum cytosolic peroxiredoxin), in the presence of 5 μCi of [ 32 P]NAD + and 5 μg of the following acceptor proteins: calf thymus histones (Sigma) or BSA (Sigma). Some assays were conducted with 0.5 μg of rLiSIR2RP1 or rLicTXNPx in the presence of 2.5 μCi of [
32 P]NAD + and 1 μg of pure tubulin or calf thymus histones. The reactions were performed at room temperature for 2 h in a buffer containing 150 mM NaCl, 10 mM DTT (dithiothreitol) and 50 mM Tris/HCl (pH 8.8), stopped with Laemmli loading buffer and dried in Whatman paper after electrophoresis, and then exposed to a film for 12 h at − 80 • C. For quantitative experiments, the reaction products were precipitated with 20 % (w/v) TCA (trichloroacetic acid), washed and counted for radioactivity after the addition of 200 μl of scintillation fluid.
Antibodies
Antibodies to LiSIR2RP1 were obtained by BALB/c mouse immunization. The mouse was injected intraperitoneally with 50 μg of rLiSIR2RP1 in 200 μl of PBS three times at 7 day intervals. At 2 weeks after the final immunization, the serum was collected. The mouse monoclonal antibody, IIIG4, against the LmSIR2 (L. major SIR2), was obtained according to Vergnes et al. [29] . Mouse monoclonal anti-α-tubulin antibody (clone DM1A) and rabbit polyclonal anti-α-tubulin antibody were purchased from NeoMarkers. Mouse monoclonal anti-acetylated tubulin antibody (clone 6-11B-1) were obtained from Sigma. Rabbit anti-T. brucei RAB11 antibodies were a gift from Professor M. C. Field (Department of Pathology, University of Cambridge, Cambridge, U.K.).
Cytoskeleton preparation
The cytoskeleton preparation was performed as described by Schneider et al. [32] . Briefly, the L. infantum promastigotes and axenic amastigotes were collected and washed three times in icecold PBS. The parasites were resuspended at a concentration of 4 × 10 7 cells/ml in a buffer containing 10 mM Mops (pH 6.9), 0.1 mM EGTA, 1 mM MgSO 4 and 0.1 % Triton X-100 supplemented with protease inhibitor cocktail (Roche), and incubated on ice for 10 min, followed by centrifugation at 3000 g for 5 min. The supernatant was collected and concentrated to one-tenth of the initial volume, and a 0.25 vol. of 4 × Laemmli sample buffer was added. The pellet was washed once with PBS and resuspended in 1/20 of the initial volume with a 1:1 mixture of PBS/Laemmli sample buffer. For immunofluorescence, the pellets were prepared as described below and, after being washed with PBS, they were attached to poly-L-lysine-coated slides.
Immunofluorescence assays
L. infantum promastigotes and axenic amastigotes were fixed with 4 % paraformaldehyde in PBS for 1 h at room temperature. After several washes, the parasites were made permeable with 0.1 % Triton X-100 in PBS and incubated for 30 min in PBS-1 % BSA (PBS containing 1 % BSA). Parasites were then incubated with primary antibodies diluted in PBS-1 % BSA for 1 h at room temperature, washed several times with PBS, and then incubated for 1 h with the Alexa Fluor ® -labelled secondary antibodies (Molecular Probes) diluted in PBS-1 % BSA at room temperature. The immunofluorescence assays using Leishmania cytoskeletons were performed as described above, with the exception of the fixation process, which was performed using 100 % methanol at 20
• C for 15 min, and the permeabilization step, which was not performed. Washed parasites or cytoskeletons were mounted in Vectashield with DAPI (4 ,6-diamidino-2-phenylindole; Vector Laboratories). Z-series optical sections were collected through the Zeiss Axio Imager Z1 microscope (Carl Zeiss), using an AxioCam. Data stacks were deconvolved using either the Axiovision AxioVs40 V 4.2.0.0 (Carl Zeiss) or the Huygens Essential version 3.0.2p1 (Scientific Volume Imaging) software. Images were treated using Adobe Photoshop CS (Adobe Microsystems). 
RESULTS
LiSIR2RP1 is an NAD + -dependent deacetylase and ADP-ribosyltransferase
The LiSIR2RP1 gene-encoding sequence was cloned into the bacterial expression vector pET28a. The fusion protein with an N-terminal tail of six histidine residues was purified under nondenaturing conditions, with the objective of studying its enzymatic activity. After purification and dialysis, the protein showed a good level of purity as evaluated by SDS/PAGE and Coomassie Blue staining ( Figure 1A, lane 1) . As expected, the recombinant protein was recognized by the monoclonal antibodies IIIG4 (antiLmSIR2 protein), previously generated by our group ( Figure 1A , lane 2) [29] . Moreover, the mouse polyclonal antibodies produced against the rLiSIR2RP1 recognized the parasite protein in total extracts from different parasite developmental stages [ Figure 1B (Pl, exponential-phase promastigotes; Ps, stationary-phase promastigotes; A, axenic amastigotes)]. It is well-established that the proteins belonging to the SIR2 family exhibit NAD + -dependent deacetylase activity due to the presence of a well-conserved enzymatic core domain of ∼ 250 amino acids [7, 8] , and this seems also to be the case for LiSIR2RP1. Indeed, as shown in Figure 2(A) , LiSIR2RP1 expressed an NAD + -dependent deacetylase activity that was not inhibited by 1 μM of the class I and II NAD + -independent deacetylase inhibitor, TSA (trichostatin A). A dose-dependent increase of the deacetylase activity catalysed by rLiSIR2RP1 was observed with increasing concentrations of NAD + up to ∼ = 0.5 mM. However, concentrations of NAD + higher than 1 mM led to a reduction in the deacetylase activity ( Figure 2B ). This phenomenon is likely to be due to the release of nicotinamide, which in turn could inhibit the LiSIR2RP1 enzymatic activity (see below). This enzyme exhibits co-factor specificity for the oxidative form of NAD + that was confirmed by the absence of deacetylase activity in the presence of the reduced form of NAD + (results not shown). Nicotinamide is one of the several products originated in the deacetylation reaction catalysed by the SIR2 family members. As shown in Figure 2 (C), the rLiSIR2RP1 was inhibited by nicotinamide in a dose-dependent manner, and the calculated nicotinamide concentration that inhibited 50 % of the enzymatic activity (IC 50 ) was 39.35 + − 5.01 μM. Several enzymatic reactions in the presence or absence of 50 μM nicotinamide and different NAD + concentrations were performed to determine whether NAD + and nicotinamide were competing for the same binding site. The Lineweaver-Burk plot of the data demonstrates that nicotinamide is an NAD + noncompetitive inhibitor ( Figure 2D ).
Some members of the SIR2 family can mediate the transfer of the ribose 5 -phosphate from nicotinic acid mononucleotide to the amino acid residues of BSA, histones or SIR2 proteins themselves [7, [21] [22] [23] [24] . To assess whether LiSIR2RP1 is an ADP-ribosyltransferase, [ 32 P]NAD + was used as a donor and BSA or calf thymus histones as acceptor proteins. A non-related Leishmania recombinant protein, rLicTXNPx1, which is produced and purified as the rLiSIR2RP1, was included as a control. The analysis of the reaction products by autoradiography revealed that LiSIR2RP1 was capable of inducing ADP-ribosylation of the histones and BSA ( Figure 3A) . However, the label intensity was stronger when histones, rather than BSA, were used as acceptor proteins. Additionally, the parasite protein was subject to auto ADP-ribosylation when incubated with the histones. No signal was detected when the proteins were incubated with [ 32 P]NAD + without an acceptor protein. A quantitative ADP-ribosyltransferase reaction catalysed by rLiSIR2RP1 using histones as the acceptor protein was carried out to characterize the factors affecting the extent of the enzymatic reaction. Increasing the concentration of rLiSIR2RP1 (2-fold) led to a decrease in the extent of the enzymatic transfer of the label, whereas a 2-fold increase of histone concentration led to an enhancement of ADP-ribosyl transfer to the acceptor target protein ( Figure 3B ). This unexpected reduction of the ribosylation reaction when adding more enzyme, might be due to some level of protein aggregation. In fact, we have experienced the purification of recombinant LiSIR2RP1 enzyme and found that, after dialysis, increasing the concentration of LiSIR2RP1 may lead to the formation of some aggregates. Given that LiSIR2RP1 is a cytosolic protein, we decided to verify whether it was capable of ADP-ribosylating tubulin. Thus purified tubulin or calf thymus histones as a control were incubated with LiSIR2RP1 or LicTXNPx in the presence of [ 32 P]NAD + . The autoradiography showed a positive but weak labelling of tubulin and LiSIR2RP1 itself, when compared with the reaction where histones were used as substrates. Even though tubulin ADPribosylation is an already reported modification, this is the first evidence of such ADP-ribosylation transfer mediated by a protein belonging to the SIR2 family [33] . This modification seems to either inhibit the in vitro assembly of microtubules or induce microtubule depolymerization of assembled microtubules [33] .
The LiSIR2RP1 is a microtubule-associated protein
We have previously reported that both LmSIR2RP1 and LiSIR2RP1 are cytosolic proteins [6, 29] . A similar cytosolic localization was reported in the case of human SIRT2 (yeast SIR2 orthologue) and a human NAD + -independent HDAC, HDAC6, both proteins have been shown to express α-tubulin deacetylase activity [15, 34] . Based on these observations and on the fact that tubulin is one of the most notable cytoplasmic proteins subjected to modification by acetylation [35] , we first investigated the cellular distribution of LiSIR2RP1 and α-tubulin. The immunostaining of both promastigote and amastigote forms revealed partial co-localization of α-tubulin with LiSIR2RP1 ( Figure 4A ). In addition to the positive signals observed in the parasite cytoplasm, punctate labelling could be seen on the periphery of both promastigote and amastigote stages. This observation suggests the possible association of LiSIR2RP1 with the cytoskeleton. In order to examine this possibility, attempts were made to isolate the parasite cytoskeleton according to the method described by Schneider et al. [32] , that allows subpellicular microtubules and the flagellar axoneme microtubules to be separated from the membrane and cytosolic components by a non-ionic detergent extraction using Triton X-100, followed by centrifugation. The cytoskeleton preparations were then allowed to react with the anti-LiSIR2RP1 antibodies. The results shown in Figure 4 (B) suggest that part of LiSIR2RP1 is associated with the cytoskeleton network of both promastigote and amastigote forms. Interestingly, punctate labelling could also be seen over the flagellar axoneme microtubules when the cytoskeleton preparation was allowed to react with anti-LiSIR2RP1 antibodies. In agreement with this, the Western blot analysis of the detergent-soluble and insoluble fractions of promastigote and amastigote forms revealed, as expected, the presence of α-tubulin in the insoluble fraction, and of LiSIR2RP1 distributed in both soluble and insoluble fractions of promastigotes and amastigotes ( Figure 4C) . Although in the case of the promastigotes the detergent-insoluble fraction contains a band of ∼ 64.6 kDa recognized by the anti-LiSIR2RP1 antibodies, its nature is presently unknown. It might be due to noncomplete reduction of LiSIR2RP1 present in a molecular complex with other parasite polypeptides. As a control, we have used an antibody to T. brucei RAB11 that cross-reacts with Leishmania homologous protein already used by others to control the purity of cytoskeleton preparations of L. major [37] . Indeed, the RAB11 is a protein found on the membrane of endosomes not associated with the cytoskeleton [36] . As shown in Figure 4 (A), the RAB11 has a different cell distribution pattern when compared with tubulin and LiSIR2RP1. Interestingly, no positive signal could be seen in immunofluorescence preparations of parasite cytoskeletons reacted with anti-RAB11 antibodies ( Figure 4B) . Moreover, the Western blot membranes dehybridized and re-probed with anti-RAB11 antibodies showed that the RAB11 protein was present exclusively in the detergent-soluble fraction of parasite extracts ( Figure 4C) , therefore supporting the specificity of the LiSIR2RP1 and α-tubulin interaction.
LiSIR2RP1 accumulates in the posterior pole of promastigotes after taxol treatment
Leishmania is a protozoan parasite characterized by a digenetic life cycle exhibiting a particular range of cell shapes mostly The cellular distribution of the LiSIR2RP1, α-tubulin and acetylated α-tubulin were analysed after 16 h of L. infantum promastigote treatment with 1 μM taxol or 5 μg/ml nocodazole at 27 • C. The parasites were fixed with paraformaldehyde, made permeable with Triton X-100 and double-labelled with mouse anti-LiSIR2RP1 antibodies and rabbit anti-α-tubulin antibodies (A) or with mouse anti-acetylated α-tubulin antibodies (6-11B-1) and rabbit anti-α-tubulin antibodies (B) followed by their respectives Alexa Fluor ® 488-(green) or Alexa Fluor ® 568-(red) conjugated IgG and counterstained with DAPI (blue). The parasites were visualized under 1000× magnification using a Zeiss Axio Imager Z1 microscope, and Z-series optical sections were collected using an AxioCam. Data stacks were deconvolved using either the Axiovision AxioVs40 V 4.2.0.0 (Carl Zeiss) or the Huygens Essential version 3.0.2p1. defined by their internal cytoskeleton. The latter is composed mainly of microtubules that are polymers of repeating α/β tubulin heterodimers and a variety of minor components known as microtubule-associated proteins. The microtubules play an important role in many cellular processes, such as mitosis, cell shape, motility, intracellular vesicle transport and organelle position. Several compounds have been described as microtubule-interacting agents, based on their ability to induce or inhibit the tubulin assembly in microtubules. Even though a high degree of tubulin amino acid conservation is found throughout evolution, there are some reports suggesting that colchicine and benzimidazoles, two classical mammalian tubulin inhibitors, had only a slight effect on the tubulin polymerization of trypanosomatids [38, 39] . On the other hand, taxol, a microtubule-network-stabilizing agent, affects the parasite cytoskeleton in a dose-dependent manner [40] . The Leishmania parasites were treated for 16 h with 1 μM of the microtubule-stabilizing agent, taxol, or with 5 μg/ml of the microtubule-network-disrupting agent, nocodazole, to analyse whether the SIR2RP1 cell distribution is affected by changes in the parasite cytoskeleton. Treatment of promastigotes with taxol led to a weak, but distinguishable, accumulation of SIR2RP1 in the posterior pole of the cell ( Figure 5A ). The treatment of parasites with nocodazole modified the tubulin distribution, such that it was mainly localized near the nucleus in the parasite body. However, LiSIR2RP1 showed no particular modification in terms of cell distribution compared with nontreated cells. Although the morphology of treated parasites differed from that of non-treated ones, their viability measured by PI (propidium iodide) incorporation and flow cytometry analysis revealed no differences. Indeed, after 16 h of treatment with 1 μM taxol or 5 μg/ml nocodazole, the percentage of PI-negative parasites + − S.D. was 98.2 + − 0.1 and 97.6 + − 0.2 % respectively, compared with 97.4 + − 0.1 % for untreated ones. Interestingly, after taxol treatment, acetylated α-tubulin accumulated in the posterior pole of the cell (Figure 5B) , coinciding with the high LiSIR2RP1-reactive zone seen in Figure 5(A) . Moreover, punctate labelling could be seen on the whole periphery of the parasites as well as the flagellum. These observations are in agreement with the notion of LiSIR2RP1 and tubulin being interacting proteins.
LiSIR2RP1 deacetylates α-tubulin
In most eukaryotes, tubulin is subject to several post-translational modifications, including detyrosination, acetylation, phosphorylation, palmitoylation, polyglutamylation and polyglycylation [41] . Tubulin acetylation occurs on Lys 40 of the α-tubulin subunit [42] . To test the ability of LiSIR2RP1 to deacetylate α-tubulin in vitro, various amounts of rLiSIR2RP1 were incubated with purified tubulin in the presence or absence of NAD + . The deacetylation of α-tubulin was analysed by Western blot with specific antibodies to either total α-tubulin or its acetylated form. As shown in Figure 6 (A), incubation of a defined amount of tubulin (0.5 μg) with increasing quantities of rLiSIR2RP1 (0.125-0.5 μg) led to a dose-dependent deacetylation of α-tubulin. Interestingly, the addition of increasing concentrations of nicotinamide, a known physiological inhibitor of SIR2 deacetylases, led to significant inhibition of tubulin deacetylation by rLiSIR2RP1.
We further explored whether LiSIR2RP1 was able to deacetylate tubulin present within polymerized microtubules. Thus addition of taxol and GTP to tubulin heterodimers led to microtubule polymerization. Under these conditions, LiSIR2RP1 still had the capacity to efficiently deacetylate tubulin. Moreover, the addition of increasing concentrations of nicotinamide in the assay samples led to the inhibition of LiSIR2RP1-mediated tubulin deacetylation ( Figure 6B ).
We then examined whether this activity also occurred when using taxol-and GTP-treated parasite extracts as a source of polymerized tubulin. As shown in Figures 6(C) and 6(D), when total extracts from promastigotes and amastigotes treated with taxol were used as a source of polymerized microtubules, LiSIR2RP1 was also able to deacetylate tubulin. Taken together, these observations demonstrate that tubulin is a substrate of LiSIR2RP1 deacetylase.
We further examined the LiSIR2RP1 NAD + -dependent deacetylase substrate specificity by using acetylated BSA or cytochrome c and Western blotting. In contrast with tubulin, the level of BSA and cytochrome c acetylation presented no changes after incubation with LiSIR2RP1 in the presence or absence of NAD + . This allowed us to conclude that, at least from the approach we have used, LiSIR2RP1 does not deacetylate either BSA or cytochrome c, suggesting some substrate specificity of LiSIR2RP1 as a deacetylase (results not shown).
In order to evaluate whether LiSIR2RP1 was deacetylating tubulin in vivo, we have analysed the ratio of acetylated tubulin to total α-tubulin in the wt and single LiSIR2RP1-knockout promastigotes and axenic amastigotes. Only a slight difference in the level of tubulin acetylation between the wt and singleknockout axenic amastigotes was detected ( Figure 6E) . However, the disruption of a single allele from the LiSIR2RP1 gene may not be enough to affect the tubulin acetylation level, even though it is enough to reduce the ability of amastigotes to multiply, be it in vitro as free forms or inside macrophages, or in vivo in Balb/c mice [30] .
DISCUSSION
In the present study, we describe and characterize, for the first time, the enzymatic activities of LiSIR2RP1. Assuming that this protein is involved in the virulence and survival of the parasite, it could constitute a new and potential drug target against leishmaniasis that needs to be exploited. We have demonstrated that, although LiSIR2RP1 differs from its T. brucei orthologue, TbSIR2RP1 [22] , in terms of subcellular localization (cytosolic compared with nuclear), it expresses similar enzymatic activities, being able to act as an NAD + -dependent deacetylase and to transfer [ 32 P]NAD + to histones and, to a lesser extent, to BSA or tubulin. Initial reports on yeast SIR2 have shown that the protein has a weak mono-ADP-ribosyltransferase activity and a more robust NAD + -dependent deacetylase activity [21] . This finding led to the general idea that the ADP-ribosyltransferase activity might be the result of a non-enzymatic reaction. However, our results and the investigations using TbSIR2RP1 [22] , human SIRT6 [23] or P. falciparum Sir2 [24] , provided evidence supporting the notion that these SIR2 family members could mediate the enzymatic transfer of the ADP-ribosyl group. Studies from Kowieski et al. [43] have recently shed light on the ADP-ribosylation mechanism catalysed by the TbSIR2RP1. The authors demonstrated that ADP-ribosylation of histone by TbSIR2RP1 required an acetylated substrate. Additionally, two distinct ADP-ribosylation pathways that involve an acetylated substrate, NAD + and TbSIR2RP1, were described. One is a noncatalytic reaction between the deacetylation product OAADPr [or its hydrolysis product, ADPr (ADP-ribose)] and histones, and the other a more efficient mechanism involving interception of an ADP-ribose-acetylpeptide-enzyme intermediate by a sidechain nucleophile from bound histone [43] . This might also explain the low level of tubulin ADP-ribosylation catalysed by the Leishmania SIR2 protein. If the enzyme preferentially deacetylates tubulin and the ADP-ribosylation requires an acetylated protein, the occurrence of the latter will be dependent on the first one [43] .
The LiSIR2RP1 possesses the expected NAD + -dependent deacetylase activity that characterizes the SIR2 family members, and one of their reaction products, nicotinamide, is an NAD + non-competitive inhibitor. Several biological activities have been attributed to the proteins belonging to the SIR2 family, that, even though sharing a conserved enzymatic core domain, are flanked at their N-and C-terminal parts by divergent sequences between family members, which may promote the binding to specific substrates [44] . Two main sirtuin substrates that have been identified are large fibrous macromolecular complexes, chromatin and tubulin [15] . The partial co-localization of LiSIR2RP1 with α-tubulin and its association with the parasite cytoskeleton, suggested that tubulin could be a substrate of this enzyme as it is for the human enzymes SIRT2 and HDAC6 [15, 34] . Control tests using antibodies to a parasite cytosolic protein, RAB11, which confirmed the absence of a RAB11-tubulin relationship, strongly support the notion of a LiSIR2RP1-tubulin-specific interaction. In fact, LiSIR2RP1 was either able to deacetylate tubulin in dimers or when present in taxol-stabilized microtubules, or in total promastigote or amastigote extracts. Although the α-tubulin acetylation has already been reported, its importance in cell biological processes is not yet completely understood [45] . The presence of acetylated tubulin in stable microtubules and the absence of highly acetylated microtubules in the fibroblast leading edge (a dynamic structure involved in cell motility), suggested that this post-translational modification could play a role in microtubule stability [45] . However, Palazzo et al. [46] demonstrated that enhanced tubulin acetylation does not increase the Purified tubulin dimers (A), taxol-stabilized microtubules (B), taxol-stabilized microtubules from whole promastigote lysate (C) and taxol-stabilized microtubules from whole amastigote lysate (D) were incubated with several amounts of purified rLiSIR2RP1 in the presence or absence of 1 mM NAD + and several nicotinamide concentrations for 3 h at room temperature. The reaction products were analysed by Western blotting with specific antibodies to acetylated α-tubulin (Ac Tubulin), α-tubulin and LiSIR2RP1. (E) Analysis by Western blot of the acetylated α-tubulin (Ac-Tubulin) and total α-tubulin levels in the wt and LiSIR2 +/− mutant (clone N2) promastigote (P) and axenic amastigote (A) total extracts.
level of stable microtubules. Moreover, ciliated or flagellated protists can use a non-acetylable α-tubulin with no observable ill effects on the microtubules or the organisms [47] . By contrast, the level of tubulin acetylation seems to affect a number of cellular events that includes the infection of CD4 + T-cells by HIV1 [48] , the binding and transport of a kinesin 1 [49] , the correct organization of the immune synapse [50] , and the dynamics of cellular adhesions [51] . Interestingly, the promastigote treatment with the microtubule-stabilizing agent, taxol, increased the number of parasites showing an accumulation of LiSIR2RP1 in the posterior pole of the cell that is enriched in acetylated α-tubulin. It is likely that LiSIR2RP1 could bind to α-tubulin and just deacetylate it in a specific step during the life cycle of the parasite. Additionally, the promastigotes infect macrophages through a receptor-mediated mechanism initiated at the posterior pole of the parasite [52] . One can hypothesize that the accumulation of LiSIR2RP1 in the posterior pole could be important to the contact site with the APC (antigen-presenting cell) during the infection. Indeed, translocation and accumulation of HDAC6, a human cytosolic deacetylase, in the immune synapse at the contact site of T-cells with APC has previously been reported [50] . Furthermore, it is noteworthy that the influence of the deacetylase activity in the cell motility versus adhesion reported by Tran et al. [51] could also be relevant to the parasites when they are infecting the host cell.
The Leishmania parasites are subject to several modifications in their morphology during their complex life cycle. Although some environmental factors, such as pH, temperature and nutrients, can trigger morphological changes in the parasite, relatively little is known about the molecular processes that mediate the cellular remodelling. Further functional studies of LiSIR2RP1 could help to discover the role of the tubulin acetylation/deacetylation and/or ADP-ribosylation in the remodelling of the parasite's morphology and the infection of host cells.
